32 results
8-K
EX-1.1
IGMS
IGM Biosciences Inc
23 Jun 23
Entry into a Material Definitive Agreement
4:41pm
regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) for the conduct of its business … or in the aggregate, to result in a Material Adverse Change.
(ss) Compliance with Health Care Laws. The Company is, and at all times has been, in compliance with all
8-K
EX-1.1
jfpqb mflo70o3wj4
30 Mar 22
IGM Announces Proposed Public Offering
5:17pm
8-K
EX-1.1
0hzlh28xjdu
9 Dec 20
Entry into a Material Definitive Agreement
5:25pm
424B5
omfd zblrt
9 Dec 20
Prospectus supplement for primary offering
5:24pm
424B5
mmij0ik0fo5y0 kd7
7 Dec 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
ubheb
7 Dec 20
Risks Related to Our Business and the Development and Commercialization of Our Product Candidates
4:58pm